Statistics

Total Visits

Views
Maintenance bacillus Calmette-Guerin immunotherapy for TaG3 or T1G3 and/or carcinoma in situ transitional cell carcinoma of the bladder: Final results of the randomized CUETO Group Study 9801320

Select a period of time:

Number of views in the range

Views
Maintenance bacillus Calmette-Guerin immunotherapy for TaG3 or T1G3 and/or carcinoma in situ transitional cell carcinoma of the bladder: Final results of the randomized CUETO Group Study 980132

Views

Views
November 20240
December 20240
January 20250
February 20250
March 20250
April 20252
May 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Spain1
United States1
 

Top cities views

Views
Council Bluffs1